ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 97 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2018. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $31,869 | +18.0% | 42,334 | +181.0% | 0.00% | – |
| Q4 2021 | $27,000 | -63.0% | 15,064 | -55.5% | 0.00% | – |
| Q3 2021 | $73,000 | -22.3% | 33,825 | +26.2% | 0.00% | – |
| Q2 2021 | $94,000 | -66.4% | 26,807 | +3.8% | 0.00% | -100.0% |
| Q4 2020 | $280,000 | -70.5% | 25,819 | -71.9% | 0.00% | -84.6% |
| Q3 2020 | $948,000 | -26.5% | 92,037 | -17.8% | 0.01% | +62.5% |
| Q4 2019 | $1,290,000 | +17.9% | 111,971 | -44.2% | 0.01% | -20.0% |
| Q3 2019 | $1,094,000 | +559.0% | 200,668 | +1333.3% | 0.01% | +400.0% |
| Q2 2019 | $166,000 | -3.5% | 14,000 | -52.8% | 0.00% | -33.3% |
| Q1 2018 | $172,000 | +48.3% | 29,642 | -6.8% | 0.00% | +50.0% |
| Q3 2017 | $116,000 | +346.2% | 31,800 | +208.6% | 0.00% | +100.0% |
| Q2 2017 | $26,000 | -7.1% | 10,303 | -2.3% | 0.00% | 0.0% |
| Q1 2017 | $28,000 | – | 10,544 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,109,867 | $42,332,000 | 29.76% |
| Versant Venture Management, LLC | 7,003,892 | $72,140,000 | 13.20% |
| Ghost Tree Capital, LLC | 1,161,375 | $11,962,000 | 3.46% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $4,944,000 | 2.54% |
| Soleus Capital Management, L.P. | 364,349 | $3,753,000 | 1.99% |
| RTW INVESTMENTS, LP | 7,234,764 | $74,518,000 | 1.79% |
| RA Capital Management | 9,410,860 | $96,932,000 | 1.77% |
| FRAZIER MANAGEMENT LLC | 1,437,028 | $14,801,000 | 1.33% |
| Casdin Capital, LLC | 2,750,000 | $28,325,000 | 1.27% |
| Avoro Capital Advisors LLC | 8,000,000 | $82,400,000 | 1.17% |